Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Algernon, Boehringer, Cytrx, Evelo, Gossamer, Humanigen, J&J, Lineage Cell, Mesoblast, Moleculin, Nabriva, Nanobiotix, Nasus, Neurorx, Regeneron, Relief, Sanofi, Targovax, Uniqure, Vaxart.